| My Account | Sitemap | Subscribe | Contact Us | Help |
Richard K. Bernstein, MD, discusses 19 proven ways to take care of your feet and avoid diabetes-related complications
Scott Brown writes about Denver Broncos quarterback Jay Cutler's life since his recent type 1 diagnosis
Justine Lorelle Blanchard looks at a chilling development among type 1 teens: skipping insulin shots and purging food as a way to achieve rapid weight loss
Beth Morrow follows up on an article we published in May about teens' problems — occasionally fatal — with insulin pumps
Diabetes Health Digital Advantage™, the free, online version of Diabetes Health magazine, virtually identical to the bi-monthly Diabetes Health print magazine, has many additional useful features.
While the pages turn in a similar fashion to a magazine's, direct hot links lead to research articles, products and advertiser sites.
Access to the amazing Diabetes Health Digital Advantage™ is through any web browser, so you can read the current issue of Diabetes Health magazine online wherever you are!
The must-have resource for physicians, educators and medical professionals who focus on the treatment of diabetes.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Latest Type 2 Medications Articles
Glumetza
Glumetza, a once-daily extended-release formulation of metformin hydrochloride, was granted FDA approval in June 2005 for the treatment of type 2 diabetes.
According to Biovail, the drug’s manufacturer, Glumetza “may offer potential advantages such as less frequent dosing and proven effectiveness in combination with other diabetes drugs.” In addition, they say that Glumetza offers “excellent tolerability that allows physicians to more quickly administer a high enough dose to provide [blood glucose] control without significantly increasing the incidence of nausea, diarrhea and other side effects that are sometimes caused by metformin products.”
Glumetza is not recommend for people with kidney problems, heart failure that is treated with medicine, or diabetic ketoacidosis. The most common side effects of Glumetza include diarrhea, nausea and upset stomach. Glumetza can also cause lactic acidosis.
Source: Biovail Corp.
147 comments - 29 Nov 2007
94 comments - 22 Aug 2007
81 comments - 14 Aug 2008
52 comments - 18 Jan 2008
Comments
Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.
When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.
For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.
Don't have your Diabetes Health Username? Register now and add your comments to all our content.
Register..
Register your Diabetes Health Username here.
Have Your Say...